PAE2 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PAE2 antibody; At1g57590 antibody; T8L23.6 antibody; Pectin acetylesterase 2 antibody; EC 3.1.1.- antibody
Target Names
PAE2
Uniprot No.

Target Background

Function
This antibody hydrolyzes acetyl esters in homogalacturonan regions of pectin. In type I primary cell walls, galacturonic acid residues of pectin can be acetylated at the O-2 and O-3 positions. Reducing the degree of acetylation of pectin gels in vitro alters their physical properties.
Database Links

KEGG: ath:AT1G57590

STRING: 3702.AT1G57590.1

UniGene: At.37001

Protein Families
Pectinacetylesterase family
Subcellular Location
Secreted, cell wall.

Q&A

Here’s a structured FAQ for researchers investigating PAR2 antibodies in academic contexts, synthesized from peer-reviewed studies and optimized for methodological depth:

Advanced Research Questions

How to resolve contradictory PAR2 activation phenotypes across studies?

PhenotypeContextMechanismSource
Pro-inflammatoryImmune-cell PAR2Drives autoimmune β-cell destruction in NOD mice
ProtectiveTissue PAR2Attenuates glomerular injury in VEGF inhibitor models
Methodological insight: Use tissue-specific knockout models (e.g., Cre-lox systems) to isolate PAR2 roles in immune vs. parenchymal cells .

What strategies improve PAR2 antibody translational potential despite low oral bioavailability?

  • Local delivery: Intranasal or intra-articular administration (tested in arthritis models) to bypass systemic exposure limitations .

  • Bispecific designs: Combine PAR2 inhibition with VEGF/TNF-α blockers to target multi-pathway diseases (e.g., atherosclerosis) .

How to validate PAR2 antibody binding modes and allosteric effects?

  • Molecular docking: Predict binding pockets (e.g., PAR2 antagonist AZ8838 binds a site distinct from the tethered ligand domain) .

  • Cryo-EM/XR: Resolve antibody-PAR2 complexes to guide affinity maturation (e.g., Fab3949 blocks ligand-receptor engagement) .

Data Analysis & Interpretation

What metrics define PAR2 antibody efficacy in migraine models?

ParameterPAR650097 (100 mg/kg)Control
Mechanical allodynia75% reductionNo effect
Plasma C<sub>avg</sub> (Day 7)96.4 µg/mLN/A
In vivo IC<sub>50</sub> multiple100×N/A
Data from ; efficacy assessed via von Frey filament testing.

Key Methodological Recommendations

  • Contradiction analysis: Contextualize PAR2 roles using dual-reporter systems (e.g., NF-κB + Wnt pathways) .

  • Target engagement: Combine in situ hybridization (RNAscope) with IHC to correlate PAR2 expression and antibody distribution .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.